Giancarlo Comi

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen et al. · Neurology · 2014 · 3.1K citations · Full text

Medicine, Neurology, Pathology +17

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos et al. · New England Journal of Medicine · 2016 · 1.9K citations · Full text

Life Sciences, Immunology, Neurology +17

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

Giancarlo Comi, Massimo Filippi, Frederik Barkhof et al. · The Lancet · 2001 · 1.1K citations

Life Sciences, Neurology, Pharmacotherapy +8

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis

Ludwig Kappos, Jack P. Antel, Giancarlo Comi et al. · New England Journal of Medicine · 2006 · 1.1K citations · Full text

Pharmacy, Neurology, Pharmacotherapy +8

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.

Giancarlo Comi, Massimo Filippi, Jerry S. Wolinsky · PubMed · 2001 · 691 citations

Pharmacy, Neurology, Pharmacotherapy +14